Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Pentair Names Robert W. Hau as CFO, Effective November 1

Pentair plc filed a Form 8-K on September 22, 2026, disclosing the appointment of Robert W. Hau as Executive Vice President and Chief Financial Officer, effective November 1, 2026, at which time Interim CFO Robert P. Fishman will resign from that role.

Anjali Anand | 22 September 2026

U.S. GoldMining Completes 2026 Whistler Drill Program

U.S. GoldMining Inc. filed a Form 8-K on September 22, 2026, disclosing the completion of its 2026 drill program targeting high-priority porphyry centers at its Whistler Gold-Copper Project in Alaska.

Nitish Kishor | 22 September 2026

Circle Internet Group Expands Binance Partnership and Raises $100 Million

Circle Internet Group, Inc. filed a Form 8-K on September 22, 2026, disclosing a five-year expanded commercial arrangement with Binance and a concurrent private placement of Class A common stock to Binance for aggregate proceeds of $100 million.

Shwetambri Chauhan | 22 September 2026

AutoZone Reports Fiscal Q4 2026 Earnings Results

AutoZone, Inc. filed a Form 8-K on September 22, 2026, disclosing that it issued a press release announcing earnings for the fiscal quarter ended August 29, 2026.

Anjali Anand | 22 September 2026

Cognex Agrees to Acquire RealSense for $500 Million

Cognex Corporation filed a Form 8-K with the SEC on September 22, 2026, disclosing a definitive agreement to acquire RealSense, Inc. in an all-cash transaction valued at $500 million.

Manish Choudhary | 22 September 2026

Cypherpunk Technologies Appoints Amanda Fabiano to Board

Cypherpunk Technologies Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing the appointment of Amanda Fabiano as a Class III director on the company's Board of Directors, effective immediately.

Shwetambri Chauhan | 22 September 2026

Lexeo Therapeutics Signs Merger Agreement to Acquire Mantle Therapeutics

Lexeo Therapeutics, Inc. filed an 8-K with the SEC on September 22, 2026, disclosing that it entered into an Agreement and Plan of Merger with Mantle Therapeutics Inc. on September 16, 2026, under which Mantle would become a wholly owned subsidiary of Lexeo.

Vinay Lochav | 22 September 2026

Tonix Pharmaceuticals Expands TONMYA Coverage to 21 Million Medicare Part D Beneficiaries

Tonix Pharmaceuticals Holding Corp. filed a Form 8-K on September 22, 2026, disclosing that it entered into a new agreement with a pharmacy benefit manager providing coverage of TONMYA to approximately 21 million Medicare Part D plan beneficiaries, effective immediately.

Aditi Sarkar | 22 September 2026

Ligand Pharmaceuticals Acquires Ryjunea Royalty Rights for $23M

Ligand Pharmaceuticals Incorporated filed a Form 8-K on September 22, 2026, disclosing that it acquired royalty and milestone payment rights relating to Santen Pharmaceutical Co., Ltd.'s Ryjunea® from Sydnexis, Inc. for $23 million upfront.

Aditi Sarkar | 22 September 2026

Viking Therapeutics Announces VK2735 Maintenance Study Top-Line Results

Viking Therapeutics, Inc. filed a Form 8-K with the SEC on September 22, 2026, reporting that the company issued a press release announcing top-line results from its maintenance study of GLP-1/GIP agonist VK2735.

Manish Choudhary | 22 September 2026
Support

Hi! How can we help you today?

Loading…